[1]
Mantovani, L.G. et al. 2019. Cost-Effectiveness Analysis of Dimethyl Fumarate in the Treatment of Relapsing Remitting Multiple Sclerosis: An Italian Societal Perspective. Farmeconomia. Health economics and therapeutic pathways. 20, 1 (Jul. 2019). DOI:https://doi.org/10.7175/fe.v20i1.1437.